跳至主要内容
临床试验/DRKS00028152
DRKS00028152已完成4 期

Outpatient remobilization after total knee and hip arthroplasties - AMB-REMOB

udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research0 个研究点目标入组 100 人开始时间: 2022年3月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
55 Years 至 80 Years(—)
性别
All

入选标准

  • Planned unilateral knee or hip replacement for gonarthrosis.
  • Relatively painless and symptom-free contralateral lower extremity (no effusion, no load-limiting pain, VAS less than 5)
  • Age between 55 and 80 years
  • Good general health with good exercise capacity (defined by exclusion criteria)
  • Inclusion of men and non-childbearing women (postmenopausal and other reasons, to be confirmed by pregnancy test in case of doubt)

排除标准

  • Previous knee or hip arthroplasty
  • Body mass index (BMI) greater than 40
  • Any conditions/states according to fresh leg vein thrombosis (shorter than 3 weeks),
  • Higher degree of joint effusion
  • infection
  • Pre-existing myopathy
  • Relevant neurological diseases with gait disturbance (Polyneuropathies, MB, Parkinson's)
  • Dementia / reduced cognitive abilities
  • Vestibular diseases with vertigo or balance disorders
  • Symptomatic cardiopulmonary disease in the past 6 months
  • Arterial hypertension not or insufficiently controlled by medication
  • Peripheral arterial occlusive disease (pAVK)
  • Malignant diseases
  • Rheumatic diseases and other internal contraindications
  • Other relevant functional impairment of the musculoskeletal system due to previous surgery, injury and degenerative diseases

研究者

发起方
udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research

相似试验